Liver/Biliary Disorders News

A case-control study in JAMA Surgery revealed that patients with end-stage liver disease had a 34% reduction in mortality after living-donor liver transplantation compared with patients who remained on a wait list for a deceased donor.

Although progress has been made in eliminating mother-to-child transmission of hepatitis B by 2030, 26% of countries have not introduced a birth dose into routine hepatitis B vaccination, noted data in Morbidity and Mortality Weekly Report.

Researchers reported excellent 10-year outcomes among patients with hepatocellular carcinoma that was downstaged to within Milan criteria prior to liver transplant, according to a multicenter analysis published in JAMA Surgery.

New research has linked the incidence of unexplained hepatitis in pediatric patients to a pair of viruses — adenovirus type F41 and adeno-associated virus 2 — as well as potential markers of genetic mutation.

Despite global declines in liver cancer mortality attributed to hepatitis B and C, liver cancer mortality rose sharply in the Americas, driven by an increase in nonalcoholic steatohepatitis, according to data published in Cell Metabolism.

In one of the largest exome-sequencing studies on liver health, researchers found rare genetic loss-of-function variants in the CIDEB gene were associated with significant protection from liver damage and disease.

Receiving an mRNA or inactivated COVID-19 vaccine did not increase the risk for acute liver injury, according to a study published in Journal of Hepatology.

Gastroenterologists and hepatologists were leaders in nonalcoholic steatohepatitis diagnosis and viewed as primary coordinators of care, but the condition is still underdiagnosed and undertreated overall, noted data in BMC Gastroenterology.

In a Healio video exclusive, Chari Cohen, DrPH, MPH, president of the Hepatitis B Foundation, and Jeff Baxter, president and CEO of VBI Vaccines, shared insights on the latest efforts in HBV treatment and prevention.

Adults who go to sleep later, snore and nap for more than 30 minutes during the day are more likely to develop metabolic dysfunction-associated fatty liver disease, according to study findings.